BioCentury
ARTICLE | Company News

California Pacific Medical Center Research Institute, Insys deal

September 22, 2014 7:00 AM UTC

The institute granted Insys an exclusive license to the institute's patent rights covering the use of the biotech's cannabidiol (CBD) to treat glioblastoma multiforme (GBM). The small molecule synthet...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article